---
schema_version: "secwatch.filing_event.v1"
accession: "0001625297-26-000021"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-14T23:55:18.476386+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Indivior launches $175M accelerated share repurchase with Barclays

## Summary
- Initial prepayment of $175M; received 3,717,473 shares from Barclays.
- Final share count based on VWAP during term; settlement by June 22, 2026.
- Part of existing $400M buyback program; $100M remains for future repurchases.
- Company reaffirms prior financial guidance; ASR reflects confidence in strategy.

## SEC filing metadata
- accession: 0001625297-26-000021
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162529726000021/0001625297-26-000021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162529726000021/indv-20260504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625297-26-000021
- JSON: https://secwatch.observer/filing/0001625297-26-000021.json
- Plain text: https://secwatch.observer/filing/0001625297-26-000021.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.